Wakamoto Pharmaceutical News

WAKAMOTO PHARMACEUTICAL: Independent Officer Notification Form

May 30 09:00

WAKAMOTO PHARMACEUTICAL: Notice of Formulation of Mid-Term Management Plan

May 15 14:00

WAKAMOTO PHARMACEUTICAL: Notice regarding the opinions of the Board of Directors of the Company on shareholder proposals

May 15 14:00

Wakamoto Pharmaceutical: Notice regarding changes in officers

Mar 22 14:00

Wakamoto Pharmaceutical: Notice of election of candidates for outside directors

Mar 22 14:00

Wakamoto Pharmaceutical: Notice Concerning the Recording of Profit from Sale of Investment Securities (Special Profit)

Mar 8 16:00

Wakamoto Pharmaceutical: Independent Officer Notification Form

Jun 1, 2023 10:00

Wakamoto Pharmaceutical: Notice Concerning the Recording of Gains (Extraordinary Profit) from the Sale of Investment Securities

Apr 27, 2023 10:30

Wakamoto Pharmaceutical: Notice Concerning the Appointment of Outside Director Candidates and Changes in Officers

Mar 27, 2023 14:00

Wakamoto Pharmaceutical: Articles of association 2022-06-23

Dec 6, 2022 14:06

Wakamoto Pharmaceutical Co Ltd: Notice on the resignation of the director

Jun 17, 2022 16:40

Wakamoto Pharmaceutical Co Ltd: Notice on the application for the selection of "standard market" for new market division

Nov 26, 2021 14:00

Wakamoto Pharmaceutical Co Ltd: Notice on taking into account the proceeds from the sale of investment securities (special interests)

Jul 26, 2021 07:30

Wakamoto Pharmaceutical Co Ltd: Notice on the formulation of the medium-term business plan

May 14, 2021 14:00

Wakamoto Pharmaceutical Co Ltd: Notice of revision of the medium-term business plan

May 27, 2020 14:00

Wakamoto Pharmaceutical Co Ltd: Notice of the scheduled release date of the financial report in March 2020

May 19, 2020 14:00

Wakamoto Pharmaceutical Co Ltd: Notice on postponing the release of the financial report of March 2020

Apr 30, 2020 14:00

Wakamoto Pharmaceutical Co Ltd: Notice on the comprehensive business cooperation with Laute Pharmaceutical Co., Ltd.

Apr 28, 2020 14:00

Wakamoto Pharmaceutical Co Ltd: Notice on taking into account the proceeds from the sale of investment securities (special interests)

Apr 28, 2020 14:00

Wakamoto Pharmaceutical Co Ltd: Notice on the suspension of the development of the therapeutic agent "WP-1303" for glaucoma hypertension

Sep 9, 2019 18:00